欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Superoxide dismutase [Mn/Fe] (sodA) CSB-YP523841FMG
CSB-EP523841FMG
CSB-BP523841FMG
CSB-MP523841FMG
CSB-EP523841FMG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium meliloti Flagellar biosynthetic protein flhB (flhB), partial CSB-YP523842RKU1
CSB-EP523842RKU1
CSB-BP523842RKU1
CSB-MP523842RKU1
CSB-EP523842RKU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Superoxide dismutase [Mn/Fe] (sodA) CSB-YP523843FNG
CSB-EP523843FNG
CSB-BP523843FNG
CSB-MP523843FNG
CSB-EP523843FNG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella typhimurium 30S ribosomal protein S11 (rpsK) CSB-YP523844SXB
CSB-EP523844SXB
CSB-BP523844SXB
CSB-MP523844SXB
CSB-EP523844SXB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Major outer membrane protein (ompH) CSB-YP523845ESF
CSB-EP523845ESF
CSB-BP523845ESF
CSB-MP523845ESF
CSB-EP523845ESF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae Urease accessory protein UreE (ureE) CSB-YP523846AXG
CSB-EP523846AXG
CSB-BP523846AXG
CSB-MP523846AXG
CSB-EP523846AXG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 3-oxoacyl-[acyl-carrier-protein] reductase FabG (fabG) CSB-YP523847EZX
CSB-EP523847EZX
CSB-BP523847EZX
CSB-MP523847EZX
CSB-EP523847EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacter agglomerans Phospho-2-dehydro-3-deoxyheptonate aldolase, Trp-sensitive (aroH) CSB-YP523848EKP
CSB-EP523848EKP
CSB-BP523848EKP
CSB-MP523848EKP
CSB-EP523848EKP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 2 Uncharacterized protein SPD_2303 (orf3) CSB-YP523849FNF
CSB-EP523849FNF
CSB-BP523849FNF
CSB-MP523849FNF
CSB-EP523849FNF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum UPF0033 protein VNG_5061C/VNG_5236C/VNG_6059C/VNG_6467C (VNG_5061C) CSB-YP523850HTM
CSB-EP523850HTM
CSB-BP523850HTM
CSB-MP523850HTM
CSB-EP523850HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat cGMP-specific 3',5'-cyclic phosphodiesterase (Pde5a), partial CSB-YP523851RA
CSB-EP523851RA
CSB-BP523851RA
CSB-MP523851RA
CSB-EP523851RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Callosciurus caniceps Alpha-1-antiproteinase CSB-YP523852CYM
CSB-EP523852CYM
CSB-BP523852CYM
CSB-MP523852CYM
CSB-EP523852CYM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Prolactin-7A2 (Prl7a2) CSB-YP523853MO
CSB-EP523853MO
CSB-BP523853MO
CSB-MP523853MO
CSB-EP523853MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Protein RoBo-1 CSB-YP523854RA
CSB-EP523854RA
CSB-BP523854RA
CSB-MP523854RA
CSB-EP523854RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine adenovirus 2 DNA terminal protein (PTP), partial CSB-YP523855BVE
CSB-EP523855BVE
CSB-BP523855BVE
CSB-MP523855BVE
CSB-EP523855BVE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human adenovirus C serotype 6 Early E3A 11.6 kDa glycoprotein, partial CSB-YP523856HWT1
CSB-EP523856HWT1
CSB-BP523856HWT1
CSB-MP523856HWT1
CSB-EP523856HWT1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized protein 061R (IIV6-061R), partial CSB-YP523857INA
CSB-EP523857INA
CSB-BP523857INA
CSB-MP523857INA
CSB-EP523857INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized protein 075L (IIV6-075L) CSB-YP523858INA
CSB-EP523858INA
CSB-BP523858INA
CSB-MP523858INA
CSB-EP523858INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized protein 094L (IIV6-094L) CSB-YP523859INA
CSB-EP523859INA
CSB-BP523859INA
CSB-MP523859INA
CSB-EP523859INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized protein 113L (IIV6-113L), partial CSB-YP523860INA1
CSB-EP523860INA1
CSB-BP523860INA1
CSB-MP523860INA1
CSB-EP523860INA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×